期刊文献+

Brn-3a在宫颈病变中的表达及其与HPV亚型的相关性研究

Brn-3a expression in cervical neoplasia and its relationship with HPV subtypes
下载PDF
导出
摘要 目的:初步探讨Brn-3a在HPV所致各级别宫颈病变中的表达及不同HPV亚型与Brn-3a表达的关系,探讨其作为CIN诊断和治疗标志物的可行性。方法:按照入组标准选取研究期间在我院就诊的月经正常、有性生活史的妇女97例为研究对象。对同一位患者的宫颈脱落细胞同时进行转录因子Brn-3a的表达及HPV分型的检测。分析每组样本Brn-3a的表达。结果:Brn-3a表达随着病变加重而升高。高级别CIN(CINⅡ、Ⅲ及原位癌)LEEP术后随访组Brn-3a表达高于宫颈良性病变(HPV-)组,差异有统计学意义(P=0.0000,<0.05);该组平均值虽高于HPV感染(HPV+)、宫颈湿疣与CINⅠ组,但二者无统计学差异(P=0.6815,>0.05);与高级别CIN组(治疗前)相比,表达量明显减少,差异有统计学意义(P=0.0002,<0.05)。不同HPV亚型所致的同级别病变中Brn-3a表达差异无统计学意义;高危型和低危型HPV感染所致的CINⅠ以下病变组中,Brn-3a表达无统计学差异(P=0.5815);同种HPV亚型所致的不同病变级别Brn-3a表达有统计学差异。结论:转录因子Brn-3a表达与HPV所致宫颈病变的病理级别相关,并非简单的反映HPV的感染状态。 Objective:To determine the expression of cellular transcription factor Brn-3a in different levels of cervical lesions caused by various subtypes of HPV, and to explore its potential as a diagnostic and treatment marker. Methods:Cervical smears from 97 women with cervical lesions were collected according to predefined standard. Every sample was tested and analyzed for Brn-3a expression and HPV subtypes. Results :The quantified level of Brn-3a corresponded to the severity of the cervical lesions. Brn-3a expression in the CIN Ⅱ,Ⅲ after LEEP was statistically higher than that in chronic cervicitis ( HPV - ) (P = 0. 0000, 〈 0.05 ) and lower than untreated high grade group ( P = 0. 0002), but its discrepancy with the HPV infection, cervical condiloma and CIN I was not statistically significant( P = 0. 6815 ). No statistically signifi- cant difference was found in Brn-3a level between diverse HPV subtypes in the same degree of cervical lesions, or between high risk and low risk subtypes of HPV (P = 0. 5815 ) when analyzed as a whole in ≤ CIN I lesions which was the only group infected by both high and low risk types of HPV. While in different degrees of cervical lesions infected with the same subtype of HPV, the expression of Brn-3a varied significantly. Conclusion: The expression of Brn-3a relates positively to histopathology, and does not vary significantly according to different HPV subtypes in the same degree of cervical lesion.
作者 肖凤仪 隋龙
出处 《现代妇产科进展》 CSCD 北大核心 2009年第7期495-498,共4页 Progress in Obstetrics and Gynecology
基金 上海市卫生局科研基金(No:2005-054063) 上海市医学重点学科建设项目(No:B-117)
关键词 转录因子 BRN-3A 宫颈上皮内瘤样病变 人乳头瘤病毒 Transcription factor Bm-3a Cervical neoplasia intraepithelial Papillomavirus, human
  • 相关文献

参考文献10

  • 1Parkin DM.The global health burden of infection-associated cancers in the year 2002[J].Int J Cancer,2006,118:3030-3044.
  • 2Ndisang D,Faulkes DJ,Gascoyne D,et al.Differential regulation of different human papilloma virus variants by the POU family transcription factor Brn-3a[J].Oncogene,2006,25:51-60.
  • 3石菊芳,吴瑞芳,刘植华,周庆芝,李霓,乌兰娜,李晴,王倩,刘彬,李瑞珍,乔友林.深圳妇女人乳头瘤病毒的型别分布[J].中国医学科学院学报,2006,28(6):832-836. 被引量:37
  • 4Gallagher RE,Yeap BY,Bi W,et al.Quantitative real-time RT-PCR analysis of PML-RAR alpha mRNA in acute promyelocytic leukemia:assessment of prognostic significance in adult patients from intergroup protocol 0129[J].Blood,2003,101:2521-2528.
  • 5Laara E.Trends in mortality from cervical cancer in the Nordic countries:association with organized screening programmes[J].Lancet,2005,4:47-49.
  • 6Schiffman M,Solomon D.Findings to date from the ASCUS-LSIL triage study (ALTS)[J].Arch Pathol Lab Med,2003,127:946-949.
  • 7Patricia C,Anne R,Alexia S,et al.Different outcome of invasive cervical cancer associated with high-risk versus intermediate-risk HPV genotype[J].Int J Cancer,2009,124:778-782.
  • 8Allan BR,Marais DJ,Denny L,et al.The agreement between cervical abnormalities identified by cytology and detection of high-risk types of human papillomavirus[J].S Afr Med J,2006,96:1186-1190.
  • 9Sindos M,Ndisang D,Pisal N,et al.Measurement of Brn-3a levels in Pap smears provides a novel diagnostic marker for the detection of cervical neoplasia[J].Gynecol Oncal,2003,90:366-371.
  • 10Wentzensen N,yon Knebel Doeberitz M.Biomarkers in cervical cancer screening[J].Dis Markers,2007,23:315-330.

二级参考文献14

  • 1刘彬,陈汶,任生达,刘新伏,马俊飞,崔剑峰,王秀荣,陈凤,乔友林.液基细胞学剩余标本筛查子宫颈病变中人乳头状瘤病毒DNA的应用[J].中华检验医学杂志,2005,28(5):495-497. 被引量:18
  • 2李洁,刘宝印,zur Hausen H,王宏,杨学志,李力,刘文,刘洪隐,陆克昭,刘旭,牛春燕,裴润芳,苏钟浦,王言贵,董继华,张桂宁,刘春杰,许吉林,林毓纯.中国妇女宫颈癌组织中人乳头瘤病毒感染及其地理分布的调查[J].中华实验和临床病毒学杂志,1996,10(1):50-55. 被引量:67
  • 3李瑞珍,石菊芳,周庆芝,吴瑞芳,李霓,乌兰娜,周艳秋,王倩,刘志红,刘彬,乔友林.应用基因芯片技术检测高危型人乳头瘤病毒在宫颈癌筛查中的评价[J].中华医学杂志,2006,86(5):307-311. 被引量:52
  • 4The International Agency for Research on Cancer.GLOBOCAN 2002 database:summary table by cancer.http://www.dep.iarc.fr.
  • 5Walboomers JM,Jacobs MV,Manos MM,et al.Human pa-pillomavirus is a necessary cause of invasive cervical cancer worldwide.J Pathol,1999,189(1):12-19.
  • 6Harper DM,Franco EL,Wheeler C,et al.Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women:a randomised controlled trial.Lancet,2004,364(9447):1757-1765.
  • 7Galloway DA.Papillomavirus vaccines in clinical trials.Lancet Infect Dis,2003,3(8):469-475.
  • 8Villa LL,Costa RL,Petta CA,et al.Prophylactic quadrivalent human papillomavirus (types 6,11,16,and 18) L1 virus-like particle vaccine in young women:a randomised dou-ble-blind placebo-controlled multicentre phase Ⅱ efficacy trial.Lancet Oncol,2005,6(5):271-278.
  • 9Cogliano V,Baan R,Straif K,et al.Carcinogenicity of human papillomaviruses.Lancet Oncol,2005,6(4):204.
  • 10Bosch FX,Manos MM,Munoz N,et al.Prevalence of human papillomavirus in cervical cancer:a worldwide perspective.International biological study on cervical cancer (IBSCC) Study Group.J Natl Cancer Inst,1995,87(11):796-802.

共引文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部